UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (294) 294
Newspaper Article (21) 21
Book Chapter (5) 5
Patent (5) 5
Book / eBook (3) 3
Dissertation (3) 3
Conference Proceeding (2) 2
Publication (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (162) 162
life sciences & biomedicine (143) 143
humans (109) 109
female (81) 81
male (81) 81
middle aged (72) 72
diabetes (52) 52
aged (50) 50
endocrinology & metabolism (47) 47
type 2 diabetes (45) 45
adult (41) 41
risk factors (33) 33
diabetes mellitus, type 2 - drug therapy (32) 32
research (27) 27
abridged index medicus (26) 26
double-blind method (25) 25
care and treatment (24) 24
clinical trials (23) 23
treatment outcome (23) 23
diabetes mellitus, type 2 - blood (22) 22
analysis (21) 21
diabetes mellitus, type 2 - complications (20) 20
cardiovascular system & cardiology (18) 18
general & internal medicine (17) 17
hypoglycemic agents - administration & dosage (17) 17
medicine, general & internal (17) 17
cardiac & cardiovascular systems (16) 16
cardiovascular disease (16) 16
dosage and administration (16) 16
drug therapy (16) 16
infant (16) 16
saxagliptin (16) 16
adamantane - analogs & derivatives (15) 15
blood glucose - metabolism (14) 14
cross-sectional studies (14) 14
dapagliflozin (14) 14
follow-up studies (14) 14
insulin resistance (14) 14
plant sciences (14) 14
cohort studies (13) 13
hypoglycemic agents - adverse effects (13) 13
hypoglycemic agents - therapeutic use (13) 13
medicine (13) 13
obesity (13) 13
patients (13) 13
usage (13) 13
adamantane - adverse effects (12) 12
complications and side effects (12) 12
dipeptides - adverse effects (12) 12
health aspects (12) 12
metformin (12) 12
weight loss (12) 12
chemistry (11) 11
glucose (11) 11
incidence (11) 11
agriculture (10) 10
blood pressure (10) 10
cardiovascular diseases (10) 10
cardiovascular diseases - epidemiology (10) 10
child, preschool (10) 10
diet (10) 10
drug therapy, combination (10) 10
hypoglycemia (10) 10
immunology (10) 10
medical colleges (10) 10
obesity - complications (10) 10
science & technology - other topics (10) 10
blood glucose - drug effects (9) 9
body mass index (9) 9
cardiovascular diseases - prevention & control (9) 9
diabetes mellitus (9) 9
growth (9) 9
hemoglobin (9) 9
hypoglycemia - chemically induced (9) 9
hypoglycemic agents (9) 9
infant, newborn (9) 9
infectious diseases (9) 9
nutritional and metabolic diseases (9) 9
original (9) 9
physical sciences (9) 9
physiological aspects (9) 9
technology (9) 9
atherosclerosis (8) 8
cardiovascular (8) 8
children (8) 8
exenatide (8) 8
glucosides - administration & dosage (8) 8
glycated hemoglobin a - metabolism (8) 8
internal medicine (8) 8
malnutrition (8) 8
medical research (8) 8
metformin - administration & dosage (8) 8
microbiology (8) 8
patient outcomes (8) 8
type 2 diabetes mellitus (8) 8
adamantane - administration & dosage (7) 7
adamantane - therapeutic use (7) 7
adolescent (7) 7
antioxidants (7) 7
diarrhea (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
Medicine(all) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
2005, Ishāʻat 2., ISBN 9698483284, 175
Book
2005, ISBN 9789698483449, 144
Book
2003, Ishāʻat 1., ISBN 9789698483197, 176
Book
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 412 - 419
Journal Article
Journal Article
Journal Article
Diabetes care, ISSN 1935-5548, 11/2015, Volume 38, Issue 11, pp. 2009 - 2017
OBJECTIVE To compare the efficacy and safety of treatment with dapagliflozin versus that with placebo add-on to saxagliptin plus metformin in patients whose... 
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemia - epidemiology | Metformin - therapeutic use | Benzhydryl Compounds - administration & dosage | Humans | Middle Aged | Male | Metformin - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Benzhydryl Compounds - adverse effects | Hypoglycemic Agents - administration & dosage | Urinary Tract Infections - chemically induced | Adamantane - therapeutic use | Adult | Female | Metformin - administration & dosage | Adamantane - administration & dosage | Hypoglycemia - chemically induced | Glucosides - adverse effects | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Dipeptides - therapeutic use | Double-Blind Method | Dipeptides - adverse effects | Treatment Outcome | Blood Glucose - drug effects | Dipeptides - administration & dosage | Urinary Tract Infections - epidemiology | Drug Therapy, Combination - methods | Glucosides - administration & dosage | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Treatment outcome | Usage | Safety and security measures | Dapagliflozin | Analysis | Clinical trials | Dosage and administration | Metformin | Saxagliptin | Prescription drugs | Diabetes | Comparative analysis | Index Medicus
Journal Article
Clinical therapeutics, ISSN 0149-2918, 01/2014, Volume 36, Issue 1, pp. 84 - 100.e9
Journal Article